Navigation
Navigation
User login
Back to top

Publications

Search the full list of publications from EUMDS.

Search

Results of the EUMDS Registry will be published in scientific articles and presented on haematological conferences, like ASH, EHA, ESH, MDS-Foundation and European LeukemiaNet meetings. Main results are summarized on the Lay summaries page.

Displaying 64 results from 64 total publications.

Stojkov et al. 2019.

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

K Stojkov,  T Silzle,  G Stussi,  D Schwappach,  J Bernhard,  D Bowen,  J Cermák,  A Dinmohamed,  C Eeltink,  S Eggmann,  P Fenaux,  U Germing,  M Haschke,  E Hellstrom-Lindberg,  M Heger,  AA van de Loosdrecht,  J Passweg,  M Pfeilstöcker,  U Platzbecker,  L Malcovati,  AM Almeida,  M Mittelman,  C Morgenthaler,  D Steensma,  V Santini,  R Stauder,  A Symeonidis,  S Schaer,  C, Maddox,  T de Witte,  J Bohlius,  N Bonadies,  Swiss Group of Clinical Cancer Research (SAKK).

Blood
Volume: 134.

Hoeks et al. 2019.

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Marlijn Hoeks,  Ge Yu,  Saskia Langemeijer,  Simon Crouch,  Louise de Swart,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermák,  Eva Hellström-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Luca Malcovati,  Aurelia Tatic,  Antonio Medina Almeida,  Ulrich Germing,  Aleksandar Savic,  Njetocka Gredelj Šimec,  Dominic Culligan,  Raphael Itzykson,  Agnes Guerci-Bresler,  Borhane Slama,  Arjan van de Loosdrecht,  Corine van Marrewijk,  Jackie Droste,  Nicole Blijlevens,  Marian van Kraaij,  David Bowen,  Theo de Witte,  Alex Smith,  EUMDS Registry Participants.

Haematologica

Swart et al. 2019.

Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients

Louise de Swart,  Simon Crouch,  Marlijn Hoeks,  Alex Smith,  Saskia Langemeijer,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermák,  Eva Hellström-Lindberg,  Reinhard Stauder,  Guillermo Sanz,  Moshe Mittelman,  Mette Skov Holm,  Luca Malcovati,  Krzysztof Madry,  Ulrich Germing,  Aurelia Tatic,  Aleksandar Savic,  Antonio Medina Almeida,  Njetocka Gredelj-Šimec,  Agnes Guerci-Bresler,  Odile Beyne-Rauzy,  Dominic Culligan,  Ioannis Kotsianidis,  Raphael Itzykson,  Corine van Marrewijk,  Nicole Blijlevens,  David Bowen,  Theo de Witte,  EUMDS Registry Participants.

Haematologica

Hoeks et al. 2019.

Transfusie-afhankelijkheid is geassocieerd met de aanwezigheid van toxische ijzersoorten en slechtere overleving bij patiënten met een laag-risico myelodysplastisch syndroom

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.

Oster et al. 2019.

A Web Application Could Help Diagnose or Exclude MDS, Providing a Noninvasive Alternative to Bone Marrow Examination

H Oster,  S Crouch,  A Smith,  G Yu,  J Ben-Ezra,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Guerci-Bresler,  D Culligan,  S Laurence,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

de Witte et al. 2019.

New prognostic indicators in MDS identified during the first 10 years of the EUropean LeukemiaNet MDS (EUMDS) Registry

T de Witte,  P Fenaux,  D Bowen,  A Symeonidis,  M Mittelman,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Tatic,  AM Almeida,  A Savic,  N Gredelj Šimec,  R Itzykson,  D Culligan,  I Kotsianidis,  L Ades,  AA van de Loosdrecht,  C van Marrewijk,  G Yu,  S Crouch,  L Malcovati,  A Smith.

Leukemia Research
Volume: 90.

Oster et al. 2019.

A Web Application Could Help in MDS Diagnosis and Obviate the Bone Marrow Examination

H Oster,  S Crouch,  A Smith,  G Yu,  B Abu Shrkihe,  B Shoham,  A Kolomansky,  J Ben-Ezra,  S Naor,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  U Germing,  MS Holm,  A Guerci-Bresler,  D Culligan,  S Laurence,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Leukemia Research
Volume: 144.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.

Haematologica

Rochau et al. 2019.

Consensus on a Core Outcome Set for Myelodysplastic syndromes

U. Rochau,  I. Stojkov,  A. Conrads-Frank,  H. Borba,  K. Koining,  M. Arvandi,  C. Van Marrewijk,  H. Garelius,  U. Germing,  A. Symeonidis,  G. Sanz,  P. Fenaux,  T. De Witte,  F. Efficace,  U. Siebert,  R. Stauder.

Leukemia Research
Volume: 135.

Hoeks et al. 2019.

Transfusion dependancy is associated with presence of toxic iron species and inferior survival in patients with lower-risk myelodysplastic syndromes

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellstrom-Lindberg,  A Tatic,  S Langemeijer,  D Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  D Swinkels,  T de Witte.

Madry et al. 2018.

Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

K Madry,  G Yu,  K Lis,  P Fenaux,  D Bowen,  A Symeonidis,  M Mittelman,  R Stauder,  J Cermák,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  A Guerci-Bresler,  D Culligan,  L Sanhes,  J Mills,  I Kotsianidis,  C van Marrewijk,  S Couch,  T de Witte,  A Smith.

Blood
Volume: 132.

Oster et al. 2018.

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

HS Oster,  S Crouch,  A Smith,  G Yu,  B Abu Shrkihe,  S Baruch,  A Kolomansky,  J Ben-Ezra,  S Naor,  P Fenaux,  A Symeonidis,  R Stauder,  J Cermak,  G Sanz,  E Hellström-Lindberg,  L Malcovati,  S Langemeijer,  U Germing,  MS Holm,  K Madry,  A Guerci-Bresler,  D Culligan,  L Sanhes,  J Mills,  I Kotsianidis,  C van Marrewijk,  D Bowen,  T de Witte,  M Mittelman.

Blood
Volume: 132.

Hoeks et al. 2018.

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

M Hoeks,  T Bagguley,  R Roelofs,  L de Swart,  D Bowen,  A Symeonidis,  C van Marrewijk,  E Hellström-Lindberg,  A Tatic,  S Langemeijer,  DJ Culligan,  M Macheta,  H Garelius,  M Spanoudakis,  S Killick,  P Panagiotidis,  O Stanca Ciocan,  J Mills,  B Pottinger,  S Ackroyd,  C Hall,  J Droste,  A Smith,  DW Swinkels,  TM de Witte.

Blood
Volume: 132.

Stojkov et al. 2018.

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Igor Stojkov,  Annette Conrads-Frank,  Ursula Rochau,  Karin A. Koinig,  Helena Borba,  Marjan Arvandi,  Pierre Fenaux,  Argiris Symeonidis,  David Bowen,  Moshe Mittelman,  Corine van Marrewijk,  Theo de Witte,  Fabio Efficace,  Uwe Siebert,  Reinhard Stauder.

Blood
Volume: 132, Issue: Supplement 1, Pages: 2295-2295.

Stauder et al. 2018.

Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

R. Stauder,  G. Yu,  K. A. Koinig,  D. Culligan,  P. Fenaux,  J. Cermak,  A. Symeonidis,  T. Bernal,  E. Hell-Strom-Lindberg,  M. Mittelman,  S. Langemeijer,  M. S. Holm,  J. Mills,  A. Guerci-Bresler,  C. van Marrewijk,  H. Garelius,  F. Efficace,  A. Smith,  D. Bowen,  T. M. de Witte.

bLOOD
Volume: 132.

Itzykson et al. 2018.

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Raphael Itzykson,  Simon Crouch,  Erica Travaglino,  Alex Smith,  Argiris Symeonidis,  Eva Hellström-Lindberg,  Guillermo Sanz,  Jaroslav Cermák,  Reinhard Stauder,  Chiara Elena,  Ulrich Germing,  Moshe Mittelman,  Saskia Langemeijer,  Krzysztof Madry,  Aurelia Tatic,  Mette Skov Holm,  Antonio Medina Almeida,  Aleksandar Savic,  Njetocka Gredelj Šimec,  Elisa Luño,  Dominic Culligan,  Agnes Guerci-Bresler,  Luca Malcovati,  Corine van Marrewijk,  David Bowen,  Theo de Witte,  Pierre Fenaux.

Blood Advances
Volume: 2, Issue: 16, Pages: 2079-2089.

Stahl et al. 2018.

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Maximilian Stahl,  Michelle DeVeaux,  Theo de Witte,  Judith Neukirchen,  Mikkael A. Sekeres,  Andrew M. Brunner,  Gail J. Roboz,  David P. Steensma,  Vijaya R. Bhatt,  Uwe Platzbecker,  Thomas Cluzeau,  Pedro H. Prata,  Raphaël Itzykson,  Pierre Fenaux,  Amir T. Fathi,  Alexandra Smith,  Ulrich Germing,  Ellen K. Ritchie,  Vivek Verma,  Aziz Nazha,  Jaroslaw P. Maciejewski,  Nikolai A. Podoltsev,  Thomas Prebet,  Valeria Santini,  Steven D. Gore,  Rami S. Komrokji,  Amer M. Zeidan.

Blood Advances
Volume: 2, Issue: 14, Pages: 1765-1772.

Stauder et al. 2018.

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Reinhard Stauder,  Ge Yu,  Karin A. Koinig,  Tim Bagguley,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Jaroslav Cermak,  Moshe Mittelman,  Eva Hellström-Lindberg,  Saskia Langemeijer,  Mette Skov Holm,  Krzysztof Madry,  Luca Malcovati,  Aurelia Tatic,  Ulrich Germing,  Aleksandar Savic,  Corine van Marrewijk,  Agnès Guerci-Bresler,  Elisa Luño,  Jackie Droste,  Fabio Efficace,  Alex Smith,  David Bowen,  Theo de Witte.

Leukemia
Volume: 32, Issue: 6, Pages: 1380-1392.

Garelius 2018.

Registry studies on myelodysplastic syndrome and secondary acute myeloid leukemia

H. Garelius.

de Swart et al. 2018.

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS

Louise de Swart,  Alex Smith,  Detlef Haase,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Guillermo Sanz,  Reinhard Stauder,  Moshe Mittelman,  Eva Hellström-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Mette Skov-Holm,  Krzysztof Madry,  Ulrich Germing,  Antonio Medina Almeida,  Aurelia Tatic,  Aleksandar Savic,  Njetocka Gredelj Šimec,  Corine van Marrewijk,  Agnes Guerci-Bresler,  Laurence Sanhes,  Elisa Luño,  Dominic Culligan,  Odile Beyne-Rauzy,  Sonja Burgstaller,  Nicole Blijlevens,  David Bowen,  Theo de Witte.

Leukemia Research
Volume: 67, Pages: 21-26.

Swart et al. 2018.

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

Louise de Swart,  Chloé Reiniers,  Timothy Bagguley,  Corine van Marrewijk,  David Bowen,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin Huls,  Jaroslav Cermak,  Arjan A. van de Loosdrecht,  Hege Garelius,  Dominic Culligan,  Mac Macheta,  Michail Spanoudakis,  Panagiotis Panagiotidis,  Marta Krejci,  Nicole Blijlevens,  Saskia Langemeijer,  Jackie Droste,  Dorine W. Swinkels,  Alex Smith,  Theo de Witte.

Haematologica
Volume: 103, Issue: 1, Pages: 69-79.

Hoeks, M. et al. 2018.

Impact van behandeling met ijzerchelatietherapie op patiënten met een laag-risico myelodysplastisch syndroom die deelnemen aan de Europese MDS registratie

Hoeks, M.,  G. Yu,  S. Langemeijer,  S. Crouch,  L. de Swart,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hell-Strom-Lindberg,  G. Sanz,  R. Stauder,  M. Skov Holm,  M. Mittelman,  K. Madry,  L. Malcovati,  A. Tatic,  A. M. Almeida,  U. Germing,  A. Savic,  N. Gredelj Šimec,  D. Culligan,  R. Itzykson,  A. Guerci-Bresler,  B. Slama,  C. Van Marrewijk,  J. Droste,  M. van Kraaij,  D. Bowen,  T. M. de Witte,  A. Smith.

de Swart et al. 2018.

Impact of Red Blood Cell Transfusion Rate, Adjusted by Therapeutic interventions, on Progression-Free Survival in Lower-Risk MDS Patients within the European LeukemiaNet MDS Registry

L. de Swart,   Hoeks, M.,  S. Crouch,  A. Smith,  S. Langemeijer,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hell-Strom-Lindberg,  R. Stauder,  G. Sanz,  M. Mittelman,  M. S. Holm,  L. Malcovati,  K. Madry,  U. Germing,  A. Savic,  A. M. Almeida,  A. Guerci-Bresler,  R. Itzykson,  O. Beyne-Rauzy,  D. Culligan,  C. van Marrewijk,  N. M. A. Blijlevens,  D. Bowen,  T. M. de Witte.


Volume: 103.

Mkadmi 2018.

Assessing whether the number of metaphases analyzed in patient with low-risk myelodysplastic syndrome and normal karyotype expose any prognostic information

H. Mkadmi.

Langemeijer and Hoeks, M. 2018.

Ijzerchelatie bij laag-risico myelodysplsie

S. Langemeijer,   Hoeks, M..

NTvH 2018 April DHC special

Symeonidis et al. 2017.

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS). a Study of the European LeukemiaNet-Based MDS (EUMDS) Registry

Argiris Symeonidis,  Ge Yu,  Alexandra Smith,  Pierre Fenaux,  Moshe Mittelman,  Reinhard Stauder,  Guillermo Sanz,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  K. Madry,  Skov Mette,  Mette Holm,  A. Tatic,  Antonio Almeida,  Alek-Sandar Savic,  Njetocka Gredelj,  David Bowen.

Oster et al. 2017.

Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model

Howard Oster,  Bander Shrkihe,  Simon Crouch,  Alexandra Smith,  Ge Yu,  Gal Carmi,  Jona-Than Ben-Ezra,  Shachar Naor,  Pierre Fenaux,  Argiris Symeonidis,  Reinhard Stauder,  Jaroslav Cer-Mak,  Guillermo Sanz,  Eva Hellstrom-Lindberg,  Luca Malcovati,  Saskia Langemeijer,  Ulrich Germing,  Skov Mette,  Mette Holm,  Moshe Mittelman.

Verwimp-Hoeks et al. 2017.

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Marlijn Verwimp-Hoeks,  Ge Yu,  Saskia Langemeijer,  Simon Crouch,  L. Swart,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Mette Holm,  Moshe Mittelman,  K. Madry,  Luca Malcovati,  A. Tatic,  Antonio Almeida,  Ulrich Germing,  Aleksandar Savic,  Alex Smith.

Itzykson et al. 2017.

A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS. a Study from the European LeukemiaNet Lower-Risk MDS (EUMDS) Registry

Raphael Itzykson,  Simon Crouch,  Alex Smith,  Argiris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Moshe Mittelman,  Saskia Langemeijer,  K. Madry,  A. Tatic,  Skov Mette,  Mette Holm,  Antonio Almeida,  Aleksandar Savic,  Njetocka Gredelj,  Pierre Fenaux.

Swart et al. 2017.

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry

L. Swart,  Simon Crouch,  Marlijn Verwimp-Hoeks,  Alex Smith,  Saskia Langemeijer,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Reinhard Stauder,  Moshe Mittelman,  Guillermo Sanz,  Eva Hell-Strom-Lindberg,  Luca Malcovati,  Skov Mette,  Mette Holm,  Ulrich Germing,  K. Madry,  Antonio Almeida,  A. Tatic,  T Witte.

de Swart et al. 2017.

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

Louise de Swart,  Alex Smith,  Marius MacKenzie,  Argiris Symeonidis,  Judith Neukirchen,  Dana Mikulenková,  Teresa Vallespí,  Gina Zini,  Malgorzata Paszkowska-Kowalewska,  Anton Kruger,  Leonie Saft,  Pierre Fenaux,  David Bowen,  Eva Hellström-Lindberg,  Jaroslav Cermák,  Reinhard Stauder,  Aurelia Tatic,  Mette Skov Holm,  Luca Malcovati,  Krzysztof Madry,  Jackie Droste,  Nicole Blijlevens,  Theo de Witte,  Ulrich Germing.

Annals of Hematology
Volume: 96, Issue: 7, Pages: 1105-1112.

de Swart et al. 2017.

280 - Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry

L. de Swart,  S. Crouch,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hellström-Lindberg,  G. Sanz,  R. Stauder,  L. Malcovati,  U. Germing,  S. Langemeijer,  M. Skov Holm,  M. Mittelman,  K. Madry,  A. Almeida,  A. Savic,  R. Itzykson,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S160-S161.

Itzykson et al. 2017.

19 - Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

R. Itzykson,  A. Smith,  P. Fenaux,  A. Symeonidis,  M. Mittelman,  R. Stauder,  G. Sanz,  J. Cermák,  E. Hellström-Lindberg,  L. Malcovati,  S. Langemeijer,  U. Germing,  K. Madry,  M. S. Holm,  A. Tatic,  A. M. Almeida,  A. Savic,  N. Gredelj Šimec,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S10-S11.

Stauder et al. 2017.

22 - Health-Related Quality of Life is Substantially Impaired in Lower-Risk MDS when Compared with Reference Populations and Significantly Affects Overall Survival

R. Stauder,  G. Yu,  K. Koinig,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermak,  M. Mittelman,  E. Hellström-Lindberg,  S. Langemeijer,  M. Skov Holm,  K. Madry,  L. Malcovati,  A. Tatic,  U. Germing,  A. Savic,  F. Efficace,  A. Smith,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 55, Pages: S12.

Garelius et al. 2017.

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome

H. K. G. Garelius,  W. T. Johnston,  A. G. Smith,  S. Park,  L. de Swart,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermák,  R. Stauder,  L. Malcovati,  M. Mittelman,  A. A. van de Loosdrecht,  C. J. van Marrewijk,  D. Bowen,  S. Crouch,  T. J. M. de Witte,  E. Hellström-Lindberg.

Journal of Internal Medicine
Volume: 281, Issue: 3, Pages: 284-299.

Langemeijer et al. 2016.

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European LeukemiaNet MDS (EUMDS) Registry

Saskia Langemeijer,  L. Swart,  Ge Yu,  Alex Smith,  Simon Crouch,  W Thomas Johnston,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Mette Holm,  Moshe Mittelman,  K. Madry,  A. Tatic,  Antonio Almeida,  Theo Witte.

Hoeks et al. 2016.

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Marlijn Hoeks,  Saskia Langemeijer,  Louise De Swart,  Tim Bagguley,  Corine van Marrewijk,  David Bowen,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Marian G. J. Van Kraaij,  Panagiotis Panagiotidis,  Hege Garelius,  Dominic J. Culligan,  Marta Krejci,  Jackie Droste,  Alexandra Smith,  Dorine W. Swinkels,  Theo de Witte.

Blood
Volume: 128, Issue: 22, Pages: 4327-4327.

Langemeijer et al. 2016.

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Saskia Langemeijer,  Louise De Swart,  Ge Yu,  Alex Smith,  Simon Crouch,  Tom Johnston,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Aurelia Tatic,  Antonio Almeida,  Aleksandar Savic,  Sophie Park,  Odile Beyne-Rauzy,  Raphaël Itzykson,  Corine van Marrewijk,  David Bowen,  Theo de Witte.

Blood
Volume: 128, Issue: 22, Pages: 3186-3186.

Stauder et al. 2016.

Comparison of 1690 MDS Patients from the European Leukemianet Registry and Reference Populations - Evidence for a Significant Impairment in Qol in MDS and Definition of Predictors of Diminished Qol

R. Stauder,  G. Yu,  T. Bagguley,  P. Fenaux,  A. Symeonidis,  G. Sanz,  J. Cermak,  M. Mittelman,  E. Hellstrom-Lindberg,  S. Langemeijer,  M. S. Holm,  K. Madry,  L. Malcovati,  A. Tatic,  U. Germing,  A. Savic,  C. van Marrewijk,  A. Guerci-Bresler,  E. Luno,  J. Droste,  K. Koinig,  A. Smith,  D. Bowen,  T. de Witte.

Haematologica
Volume: 101, Pages: 16-17.

De Swart et al. 2015.

Prognostic Impact of Transfusions Intensity on Survival and Development of Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet EU-MDS Registry

Louise De Swart,  Tom Johnston,  Alexandra Smith,  Pierre Fenaux,  Argiris Symeonidis,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Guillermo Sanz,  Reinhard Stauder,  Luca Malcovati,  Ulrich Germing,  Gerwin Huls,  Mette Skov Holm,  Moshe Mittelman,  Krzysztof Madry,  Aurelia Tatic,  Antonio Medina Almeida,  Aleksandar Savic,  Sophie Park,  Odile Beyne-Rauzy,  Raphaël Itzykson,  Corine van Marrewijk,  David Bowen,  Theo de Witte.

Blood
Volume: 126, Issue: 23, Pages: 1677-1677.

De Swart et al. 2015.

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart,  Chloé Reiniers,  Tim Bagguley,  David Bowen,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin Huls,  Panagiotis Panagiotidis,  Hege Garelius,  Dominic Culligan,  Marta Krejci,  Corine van Marrewijk,  Jackie Droste,  Alexandra Smith,  Dorine W. Swinkels,  Theo de Witte.

Blood
Volume: 126, Issue: 23, Pages: 2865-2865.

de Swart et al. 2015.

Prognostic Impact of Transfusion Intensity on Survival and Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

L. de Swart,  W. T. Johnston,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  E. Hellström-Lindberg,  G. Sanz,  R. Stauder,  L. Malcovati,  U. Germing,  G. Huls,  M. S. Holm,  M. Mittelman,  K. Madry,  A. Tatic,  A. M. Almeida,  A. Savic,  S. Park,  O. Beyne-Rouzy,  R. Itzykson,  J. Droste,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 39, Pages: S23-S24.

de Swart et al. 2015.

Transfusions and Presence of Ringsideroblasts Influence Hepcidin and NTBI Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) - a Report from the European Leukemianet MDS Registry

L. de Swart,  C. Reiniers,  T. Bagguley,  C. Van Marrewijk,  D. Bowen,  J. Cermak,  E. Hellström-Lindberg,  A. Tatic,  A. Symeonidis,  G. Huls,  P. Panagiotidis,  H. Garelius,  D. Culligan,  M. Krejci,  J. Droste,  A. Smith,  D. Swinkels,  T. de Witte.

Leukemia Research
Volume: 39, Pages: S106-S107.

Swart et al. 2015.

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

Louise de Swart,  Alex Smith,  Thomas W. Johnston,  Detlef Haase,  Jackie Droste,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Eva Hellström-Lindberg,  Jaroslav Cermák,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette S. Holm,  Antonio M. Almeida,  Krzysztof Madry,  Borhane Slama,  Agnes Guerci-Bresler,  Laurence Sanhes,  Odile Beyne-Rauzy,  Elisa Luño,  David Bowen,  Theo de Witte.

British Journal of Haematology
Volume: 170, Issue: 3, Pages: 372-383.

Stauder et al. 2015.

Determinants of Health-Related Quality of Life in Elderly MDS-Patients - A study from the European LeukemiaNet MDS Registry

R. Stauder,  T. Bagguley,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  G. Sanz,  E. Hellstrom-Lindberg,  M. Mittelman,  L. Malcovati,  G. Huls,  K. Madry,  U. Germing,  A. Tatic,  M. Skov Holm,  A. Savic,  J. Droste,  A. Guerci-Bresler,  B. Slama,  E. Luno,  D. Culligan,  L. De Swart,  T. Johnston,  D. Bowen,  T. de Witte.

SIOG

Stauder et al. 2015.

Impact of MDS on Health-Related Quality of Life: A Comparison of IPSS Low-and Int-1 Risk MDS Patients from the European Leukemianet MDS (EUMDS) Registry and European Reference Populations

R. Stauder,  T. Bagguley,  A. Smith,  P. Fenaux,  A. Symeonidis,  J. Cermak,  G. Sanz,  E. Hellstrom-Lindberg,  M. Mittelman,  L. Malcovati,  G. Huls,  K. Madry,  U. Germing,  A. Tatic,  M. S. Holm,  A. Savic,  J. Droste,  A. Guerci-Bresler,  B. Slama,  E. Luno,  D. Culligan,  L. De Swart,  W. T. Johnston,  D. Bowen,  T. de Witte.

Haematologica
Volume: 100.

De Swart et al. 2014.

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart,  Chloé Reiniers,  Tim Bagguley,  Corine van Marrewijk,  David Bowen,  Jaroslav Cermak,  Eva Hellström-Lindberg,  Aurelia Tatic,  Argiris Symeonidis,  Gerwin A. Huls,  Alex Smith,  Theo de Witte.

Blood
Volume: 124, Issue: 21, Pages: 3267-3267.

Reiger et al. 2014.

Assessment of quality of life – a comparison of a German reference population a cohort from an Innsbruck senior fair and MDS-patients

A. Reiger,  G. Kemmler,  V. Bach,  S. Burgstaller,  L. de Swart,  A. Smith,  D. Bowen,  P. Fenaux,  T. de Witte,  R. Stauder.

Frühjahrstagung

Swart et al. 2013.

Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry

Louise de Swart,  Alex Smith,  Tom Johnston,  Detlef Haase,  Jackie Droste,  Pierre Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  Eva Hellström-Lindberg,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Antonio Medina Almeida,  Krzysztof Madry,  Borhane Slama,  Agnès Guerci-Bresler,  Laurence Sanhes,  Odile Beyne-Rauzy,  Elisa Luño,  David Bowen,  Theo de Witte.

Blood
Volume: 122, Issue: 21, Pages: 2770-2770.

Garelius et al. 2013.

European distribution of usage and impact on outcome for treatment with erythropoietic stimulating agents within the EUMDS lower-risk registry programme

H. Garelius,  W. T. Johnston,  A. A. Van de Loosdrecht,  S. Park,  L. De Swart,  R. Stauder,  A. Symeonidis,  G. Sanz,  J. Cermak,  O. Georgescu,  M. Skov-Holm,  U. Germing,  P. Fenaux,  M. MacKenzie,  L. Malcovati,  K. Madry,  A. M. Antonio Medina Almeida,  D. Bowen,  T. De Witte,  A. Smith,  E. Hellström-Lindberg.

Leukemia Research
Volume: 37, Pages: S21-S22.

Stauder et al. 2013.

A longitudinal observational study on the health-related quality of life in IPSS low-risk MDS - impact of time course and transfusion need

R. Stauder,  T. Jonston,  A. Smith,  P. Fenaux,  J. Droste,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. MacKenzie,  O. Beyne-Rauzy,  L. Malcovati,  A. Guerci,  L. Sanhes,  B. Iama,  E. Luno,  D. Bowen,  T. de Witte.

Haematologica
Volume: 98, Pages: 81.

Garelius et al. 2013.

European pattern and impact of the use of erythropoietic agents (ESAs) in low and int-1 risk with propensity scoring techniques in observational longitudinal studies

H. Garelius,  W. T. Johnston,  A. A. Van de Loosdrecht,  S. Park,  L. de Swart,  R. Stauder,  A. Symeonidis,  G. Sanz,  J. Cermak,  O. Georgescu,  M. Skov Holm,  U. Germing,  P. Fenaux,  M. MacKenzie,  L. Malcovati,  K. Madry,  A Medina Almeida,  D. Bowen,  T. de Witte,  A. Smith,  E. Hellstrom-Lindberg.

Haematologica
Volume: 98, Pages: 87-88.

de Swart et al. 2012.

Early Mortality in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European Leukemianet MDS (EUMDS) Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  Guillermo Sanz,  Eva Hellstrom-Lindberg,  Argyris Symeonidis,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Krzysztof Madry,  Sophie Park,  Odile Beyne-Rauzy,  Jackie Droste,  David Bowen,  Theo de Witte.

Blood
Volume: 120, Issue: 21, Pages: 3830-3830.

Itzykson et al. 2012.

Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy From the European Leukemianet Low Risk MDS (EUMDS) Registry

Raphael Itzykson,  Alex Smith,  Theo M. de Witte,  Jackie Droste,  Reinhard Stauder,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Mette Skov-Holm,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  David Bowen,  Pierre Fenaux.

Blood
Volume: 120, Issue: 21, Pages: 700-700.

de Swart et al. 2011.

Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  David Bowen,  Guillermo Sanz,  Eva Hellström-Lindberg,  Argyris Symeonidis,  Jaroslav Cermak,  Ulrich Germing,  Reinhard Stauder,  Otilia Georgescu,  Marius MacKenzie,  Luca Malcovati,  Mette Skov Holm,  Sophie Park,  Odile Beyne-Rauzy,  Jackie Droste,  Theo de Witte.

Blood
Volume: 118, Issue: 21, Pages: 2775-2775.

Stauder et al. 2011.

Health-related quality of life in low-risk MDS patients from the European LeukemiaNet Registry: Correlation with age, gender and decreased survival

R. Stauder,  A. Smith,  T. de Witte,  J. Proste,  P. Fenaux,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. Mac Kenzie,  O. Beyne-Rauzy,  L. Malcovati,  D. Bowen.

Leukemia Research
Volume: 35, Pages: S12.

de Swart et al. 2011.

Management of 1000 patients with low- and intermediate-1 risk myelodysplastic syndromes in the European LeukemiaNet MDS Registry

L. de Swart,  A. Smith,  P. Fenaux,  A. Symeonidis,  E. Hellström-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  U. Germing,  M. MacKenzie,  O. Beyne-Rauzy,  L. Malcovati,  R. Stauder,  J. Droste,  D. Bowen,  T. de Witte.

Leukemia Research
Volume: 35, Pages: S3.

de Swart et al. 2010.

Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry

Louise de Swart,  Alex Smith,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellström-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  Reinhard Stauder,  Jackie Droste,  David Bowen,  Theo de Witte.

Blood
Volume: 116, Issue: 21, Pages: 2917-2917.

Bowen et al. 2010.

The Population-Based ‘real world’ of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients

David Bowen,  Alex Smith,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo F. Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Reinhard Stauder,  Odile Beyne-Rauzy,  Luca Malcovati,  Theo de Witte.

Blood
Volume: 116, Issue: 21, Pages: 1867-1867.

Stauder et al. 2010.

Health-Related Quality of Life In Newly Diagnosed Low Risk and Intermediate-1 Risk MDS: Report on the First 683 Patients From the European LeukemiaNet Registry

Reinhard Stauder,  Alex Smith,  Theo de Witte,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo F. Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Odile Beyne-Rauzy,  Luca Malcovati,  David Bowen.

Blood
Volume: 116, Issue: 21, Pages: 3999-3999.

Stauder et al. 2010.

Assessment of Health-Related Quality of Life at Diagnosis in an European Registry for Low Risk and Intermediate-1 Risk MDS: Report of the first 322 patients

R. Stauder,  A. Smith,  T. de Witte,  J. Droste,  P. Fenaux,  A. Symeonidis,  E. Hellstrom-Lindberg,  G. Sanz,  J. Cermak,  O. Georgescu,  M. MacKenzie,  O. Beyne-Rauzy,  D. Bowen.

Haematologica
Volume: 95, Pages: 131-132.

de Witte et al. 2009.

European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients.

T. M. de Witte,  Alex Smith,  Jackie Droste,  Pierre Fenaux,  Argyris Symeonidis,  Eva Hellstrom-Lindberg,  Guillermo Sanz,  Jaroslav Cermak,  Otilia Georgescu,  Ulrich Germing,  Marius MacKenzie,  Reinhard Stauder,  Odile Beyne Rauzy,  David T. Bowen.

Blood
Volume: 114, Issue: 22, Pages: 3811-3811.

Bowen et al. 2009.

European LeukemiaNet registry programme for low/INT1 IPSS score myelodysplastic syndromes

David Bowen,  Jacqueline Droste,  Alexandra Smith,  P. Fenaux,  Argiris Symeonidis,  Guillermo Sanz,  E. Hellström-Lindberg,  J. Cermak,  Radu Gologan,  U. Germing,  Reinhard Stauder,  L. Malcovati.

Leukemia Research - LEUK RES
Volume: 33.